Trial Profile
Pilot study of dose-dense (biweekly) carboplatin plus paclitaxel with or without trastuzumab as neoadjuvant treatment for breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Aug 2015
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Paclitaxel (Primary) ; Trastuzumab (Primary)
- Indications Early breast cancer
- Focus Therapeutic Use
- 31 Aug 2015 New trial record